A day of science. A community of purpose.
On November 4, our community came together at the Magnolia Hotel Denver not just to discuss where HBV cure research is heading, but to confront what the science demands of us right now.
Across a full day, one theme kept emerging: progress is happening, but the path to functional cure will require collaboration, honest data, and the willingness to challenge what we think we know. How do we refine the biomarkers that predict cure? How do we bring combination therapies closer to patients? How do we ensure that the pipeline reflects the populations who need it most?
From Adam Gehring’s opening remarks to the round table discussions that carried the conversation well past the scheduled time, and closing with the HBV & HDV Forum 17, the 13th International HBV Cure Workshop 2026 made one thing clear: the science that will shape the future of HBV cure is being built by the people in this room. The conversations that started here will continue well beyond today.
Save the date for the 14th International HBV Cure Workshop 2027 on November 11, 2027, right before the The Liver Meeting® (TLM) 2027 by AASLD. We look forward to seeing you next year!
Harry Janssen, MD, PhD
Erasmus MC, University Hospital Rotterdam, the Netherlands
Director, The Global Hepatitis Association
Adam Gehring, PhD
Toronto Centre for Liver Disease, Canada
Director, The Global Hepatitis Association